ShockWave Medical, Inc. (SWAV)
NASDAQ: SWAV · IEX Real-Time Price · USD
329.00
+1.48 (0.45%)
At close: Apr 19, 2024, 4:00 PM
328.14
-0.86 (-0.26%)
After-hours: Apr 19, 2024, 7:12 PM EDT

ShockWave Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
147.28216-9.14-65.7-51.11-41.1-30.62
Depreciation & Amortization
13.527.95.543.352.280.70.47
Share-Based Compensation
73.2344.8927.2610.353.651.30.97
Other Operating Activities
-37.98-151.05-8.62-19.18-2.93-2.36-1.17
Operating Cash Flow
196.05117.7315.04-71.18-48.11-41.47-30.35
Operating Cash Flow Growth
66.52%683.00%-----
Capital Expenditures
-30.6-25.13-12.44-11.52-3.82-1.98-0.43
Acquisitions
-94.41000000
Change in Investments
-500.72-37.0238.86-95.95-55.731.81-1.81
Investing Cash Flow
-625.73-62.1526.42-107.47-59.54-0.17-2.23
Share Issuance / Repurchase
7.67.055.8989.48209.720.530.34
Debt Issued / Paid
609.085.9702.15-1.6714.99-1.56
Other Financing Activities
-16.28-0.02-8.34-1.6-14.2934.91
Financing Cash Flow
600.413-2.4590.04208.0529.8133.69
Exchange Rate Effect
0.8-1.1500000
Net Cash Flow
171.5267.4339-88.62100.4-11.831.11
Free Cash Flow
165.4692.612.6-82.7-51.92-43.45-30.77
Free Cash Flow Growth
78.67%3465.88%-----
Free Cash Flow Margin
22.66%18.91%1.10%-122.00%-120.96%-354.29%-1790.11%
Free Cash Flow Per Share
4.512.580.07-2.50-2.17-24.73-19.81
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).